Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Urogenital Neoplasms × Abiraterone Acetate × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Interventional 1 Expanded_access 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urogenital Neoplasms 1 Prostatic Neoplasms 1 Metastatic Castration-resistant Prostate Cancer 1 Genital Neoplasms, Male 1 Genital Diseases, Male 1

Interventions

Suspensions 1 Powders 1 Docetaxel 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01217697 2017-03-24

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Approved for marketing

Genital Diseases, Male, Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡